Medical Forum / Diseases and Disorders / Prostate Cancer / November 2004
What am I missing here??
|
|
Thread rating:  |
Smith - 05 Nov 2004 01:15 GMT This is a passage from Businessweek:
"POTENTIAL RISK." The problem with the PSA test is that it's too sensitive -- and that can lead to unnecessary treatments with nasty side effects, including incontinence and impotence. In a large prevention trial for prostate cancer sponsored by the National Institutes of Health, screening patients with the PSA test produced a high rate of both false positives (no cancer, but test implies its presence) and false negatives (cancer, but test suggests its absence)."
Note the first sentence. It's basically saying the PSA test is too sensitive that leads to unnecessary treatments. Well, where the hell does the biopsy come into play, it's the biopsy that will determine whether to cut or not, right? I believe this paragraph is pretty misleading (or maybe I'm wrong).
I was doing some research on FreePSA, btw.
http://www.businessweek.com/technology/content/sep2004/tc20040930_8208_tc119.htm
DonC - 05 Nov 2004 03:10 GMT > This is a passage from Businessweek: > [quoted text clipped - 16 lines] > > http://www.businessweek.com/technology/content/sep2004/tc20040930_8208_tc119.htm Now, let's not be to hard on the author. They have to make a living by filling space. And then YOU come along and expect that they also include accuracy and sense. Geeez......
Just kidding. It's one of my pet peeves too. Sometimes I think people who's writing (or speaking) effects the health and well being of people should require a license to publish. I know the First Amendment crowd will scream but we DO require licensing of doctors, pharmacists, etc.
ButtercupsDad@dog.net - 05 Nov 2004 13:41 GMT >Now, let's not be to hard on the author. They have to make a living by >filling space. And then YOU come along and expect that they also include >accuracy and sense. Geeez...... some people are so damn picky :) .
Smith - 05 Nov 2004 17:22 GMT > Now, let's not be to hard on the author. They have to make a living by > filling space. And then YOU come along and expect that they also include [quoted text clipped - 4 lines] > require a license to publish. I know the First Amendment crowd will scream > but we DO require licensing of doctors, pharmacists, etc. There were parts of the article that were interesting. Along with PC, and many other ailments, I wish the authors of articles that write about such cases would first do some good research.
Stephen Jordan - 05 Nov 2004 19:03 GMT Quoting DonC:
>>Now, let's not be to hard on the author. They have to make a living by >>filling space. And then YOU come along and expect that they also include [quoted text clipped - 8 lines] > and many other ailments, I wish the authors of articles that write > about such cases would first do some good research. Rant mode on.
'Scuse me, but haw haw. One should not expect most reporters to do research. Generally, they're too ignorant and lazy.
I have an ongoing peeve with my local newsrag regarding lousy English usage. The managing editor won't respond to me beyond a patronizing reply a few months ago which essentially said that he won't do anything to educate his employees (well, maybe he's not qualified).
Rant mode off.
Regards,
Steve J __ "You can fool some of the people some of the time, and those are the ones you need to concentrate on." --Christopher Buckley
c palmer - 05 Nov 2004 04:11 GMT hi smith - the bottom line on the psa test is that some people want to treat it as THE final word. it is simply a tool that can used in conjunction with the DRE, free psa II test, and biopsy.
they are right when they say that the psa can give false positives, but the psa test is doing it's job. now, what did i mean by that?
you may have a prostate infection and get a psa testing and it may come back in the 30's. boy, wouldn't that make you run to the uro. but after treating the infection, your psa would go back into the normal range. did they make the psa wrong? no, it tested what it was suppose to.
another case in point. you can have an ejaculation and it will drive up the psa reading. again, is the psa test at fault?
or how about getting a STD? certainly that might drive up the psa.
but to make a blanket statement that the number of the psa test will clearly indicate that you do or do not have prostate cancer is totally off base.
now, with that said, i will give some facts about my case. i hadn't had a psa test for 5 years. my psa came back at 5.79 with a negative DRE. they decided to treat me with a 2 week round of antibiotics. it dropped a little bit, but not much. they weren't happy with the psa number and sent me to the uro dept, which took another psa test with the understanding that if it was 3.99999 we would NOT do the biopsy, but if it was 4.0000 we WOULD do a biopsy. psa test came by at 6.25. biopsy confirmed cancer in both lobes. at time of surgery psa was already at 6.35 and i had a DRE done within a few hours of surgery and they still could not "feel" any lumps or signs that i had cancer knowing all the tests confirmed it.
would i put my faith into the psa test - you betcha. it was the ONLY test that sounded the alarm. but one has to remember, figures don't lie, but liars did figure. keep that in mind when you read about somebody taking a stance for or against a concept and read inbetween the lines. you might be surprised what the true meaning is.
just my .02 cents
~ curtis
knowledge is power - growing old is mandatory - growing wise is optional "Many more men die with prostate cancer than of it. Growing old is invariably fatal. Prostate cancer is only sometimes so."
Smith - 05 Nov 2004 17:37 GMT >... > hi smith - the bottom line on the psa test is that some people want to > treat it as THE final word. it is simply a tool that can used in > conjunction with the DRE, free psa II test, and biopsy. It seems that perhaps one test that *might* get used as the final word one day is the FreePSA. But perhaps only if it's combined with another marker to confirm PC.
"USING MULTIPLE MARKERS. The scientist is one of the authors of an article on the protein that appeared in the Journal of Urology's October issue. AMACR was present in the urine of all prostate cancer patients tested, while it was seen in only 42% of patients who didn't have cancer. Nelson suspects that the 42% that tested for the protein may be more prone to get the disease in the future."
I emailed Dr Catalina for his opinion on the AMACR marker (don't know if I'll get a response).
> they are right when they say that the psa can give false positives, but > the psa test is doing it's job. now, what did i mean by that? [quoted text clipped - 4 lines] > range. did they make the psa wrong? no, it tested what it was suppose > to. Exactly, and I think that's where the FreePSA test can come into and help decipher if it's an infection or not.
> another case in point. you can have an ejaculation and it will drive > up the psa reading. again, is the psa test at fault? [quoted text clipped - 16 lines] > could not "feel" any lumps or signs that i had cancer knowing all the > tests confirmed it. So let me ask you this, if your PSA came back at a reading of 3.999, would you demand your uro do a biopsy or would you go with his word and not do one? Would he wait another year to have you tested again?
> would i put my faith into the psa test - you betcha. it was the ONLY > test that sounded the alarm. but one has to remember, figures don't > lie, but liars did figure. keep that in mind when you read about > somebody taking a stance for or against a concept and read inbetween the > lines. you might be surprised what the true meaning is. Well, this brings up a few other subjects I'd like to talk about. FreePSA, PSA density and PSA Velocity.
Larry - 05 Nov 2004 04:13 GMT I agree. A PSA test alone does not lead to unnecessary treatments. It may signal a desire to test further. Only after a biopsy and a conclusive finding that cancer is present will men be treated for PCa. How does someone so incompetent get published in Business Week???
Larry
> This is a passage from Businessweek: > [quoted text clipped - 14 lines] > > I was doing some research on FreePSA, btw. http://www.businessweek.com/technology/content/sep2004/tc20040930_8208_tc119.htm
ButtercupsDad@dog.net - 05 Nov 2004 13:48 GMT >I agree. A PSA test alone does not lead to unnecessary treatments. It may >signal a desire to test further. Only after a biopsy and a conclusive >finding that cancer is present will men be treated for PCa. How does someone >so incompetent get published in Business Week??? > >Larry It seems that being incompetent is no bar to being successful in a career. I have seen several in my time.
Smith - 05 Nov 2004 17:23 GMT > I agree. A PSA test alone does not lead to unnecessary treatments. It may > signal a desire to test further. Only after a biopsy and a conclusive > finding that cancer is present will men be treated for PCa. How does someone > so incompetent get published in Business Week??? Good question, because I've always liked Businessweek. I've been a long time reader of BW. (and WSJ)
ButtercupsDad@dog.net - 05 Nov 2004 13:46 GMT My primary care doc did not do the PSA test because of the false positives, and then a biopsy would be required to know for sure. He explained in detail how it worked, and then left the final decision up to me. I trusted his opinion and just went with the DRE. When mine was diagnosed it was T1C, PSA 5.0, PSA Free 6%, Gleason 6, and only 6% in two cores on biopsy, so it was caught early. Having the PSA at all was just a fluke, insurance nurse physical, so I was lucky. I could have gone ten more years and ended up with who knows what?
Yes, I agree, the article is lacking in fundamental logic here. The author missed something for sure.
Thank you. David S.
>This is a passage from Businessweek: > [quoted text clipped - 16 lines] > >http://www.businessweek.com/technology/content/sep2004/tc20040930_8208_tc119.htm Leonard Evens - 05 Nov 2004 21:37 GMT > This is a passage from Businessweek: Is there any reason to believe that Businessweek or its reporters have any special expertise which qualifies them to make recomendations concerning medical issues? I doubt it.
> "POTENTIAL RISK." The problem with the PSA test is that it's too > sensitive -- and that can lead to unnecessary treatments with nasty [quoted text clipped - 10 lines] > whether to cut or not, right? I believe this paragraph is pretty > misleading (or maybe I'm wrong). There is a big debate still ongoing in the medical community about the advantages of PSA testing. But this refers mainly to how useful it is as a public health measure when applied to the population as a whole. Urologists by and large think it is good idea, but other groups including some epideimiologists don't. The scientific debate invovles considerable subtleties, but when they get out into the general media, these subtleties are glossed over and you see idiotic statements like that you refer to.
PSA testing, by iteself, is not dangerous. The dangers, if any, are relatively remote consequences of testing. The critics of testing argue that general testing will detect many cancers which in fact need not be treated. If those cancers are treated, a certain number of the men involved will suffer significant negative side effects. So the problem from a public health perspective is whether the net gain in reducing prostate cancer mortality and improving the lives of men whose cancers are treated is greater or less than the net negative consequences of treating men whose cancers don't need treatment. Talking about this is made more complicated by the fact that no one knows how many cancers which are currently being treated need not be treated, and there are no really hard figures on how much better off men who are treated by radiation and surgery for early prostate cancer than are men who are not so treated and later develop metastatic cancer which has to be treated by HT.
Unfortunately the critics have gone to the general public, as have the proponents to a much lesser degree. In so doing they make exaggerate claims about the innocuousness of prostate cancer and/or the futility of treating it. This is often picked up by the media.
In this particular case, the reporter has even got the critics argument wrong. The PSA test is indeed "too sensitive" in that it produces a lot of false positives. That by itself would not be all that serious since many other medical screening tests do the same thing. But as you point out, the consequence of such a false positive is an unnecessary biopsy. biopsy does have some minor risks but by and far it is a simple, safe procedure. The issue is really what happens when the biopsy is positive (so the PSA test was not a false positive). It is in that case that the question arises as to whether the cancer should be treated aggressively. As noted above, we don't really know how many such cases there are and, more important, which such cases really need to be treated.
But it should be noted that in many respects the two sides of the debate are not really that far apart. The critics mostly would agree that certain men who are at high risk for prostate cancer should have regular PSA tests, and those in favor of PSA testing usually don't think it is necessary for men past a certain age who are unlikely to benefit from aggressive treatment if a cancer is detected.
> I was doing some research on FreePSA, btw. > > http://www.businessweek.com/technology/content/sep2004/tc20040930_8208_tc119.htm Stephen Jordan - 05 Nov 2004 22:48 GMT On November 5, Leonard Evens performed a service by posting:
> Is there any reason to believe that Businessweek or its reporters have > any special expertise which qualifies them to make recomendations > concerning medical issues? I doubt it. And an excellent review of the status of the PSA debate.
Well done!
Regards,
Steve J __ "Well, I've wrestled with reality for thirty-five years, Doctor, and I'm happy to state I finally won out over it." -- James Stewart as Elwood P. Dowd in "Harvey"
|
|
|